Colorado’s life sciences community is relentlessly focused on patients. In this interactive panel, Colorado BioScience Association President & CEO along with the other panelists, will share real-world practices for embedding patient perspectives into product development, education, and access strategies - building trust and transparency through advocacy partnerships and ensuring that policy discussions reflect the patient voice. The conversation will include lessons learned from a National Dialogue on Schizophrenia that united advocates, clinicians, and policymakers for collaborative problem-solving, and a Colorado BioScience Association Day at the Capitol with patients that highlighted how patient perspectives can inform balanced approaches to state-level policy. Together, speakers will examine how advocacy strengthens the ecosystem’s collective response to complex policy challenges, including the work of Colorado’s Prescription Drug Affordability Board (PDAB). Attendees will gain practical guidance for fostering patient-centered dialogue that advances innovation, access, and affordability.